Drug
Fluocinonide clinical trials
- studies test it
- 3
- open now
- 1
- in phase 3
- 0
- first study started
- 2008
Keep track of what changes. Save the Fluocinonide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Brand
Studies by the year they started
3 studies that test it; most in 2008 (1)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 1
- Phase 4
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 3
Oregon Health and Science University (1) · Instituto Mexicano del Seguro Social (1) · Northwestern University (1)
Often tested with
Tested in the same studies.
Urea (1) · Tazarotene (1)
Studies
Open first, then newest update. How each study uses Fluocinonide is read from its arms, and is right about nine times in ten.
Testing it · 3
- Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery.RecruitingPhase 4Instituto Mexicano del Seguro SocialNCT07073846Written as Lidocaine + Dexmedetomidine Combination (LIDEX) + Standard Anesthesia
- VANOS Cream and Skin Barrier FunctionCompletedPhase 4Oregon Health and Science UniversityNCT00819507Written as Fluocinonide
- Sorafenib-induced Hand- Foot Skin Reaction TreatmentTerminatedPhase 2Northwestern UniversityNCT00667589Written as fluocinonide 0.05% cream
Given in every arm · 2 — Fluocinonide is usual care beside what is tested
- Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)RecruitingPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT06504160Written as Fluocinonide Ointment
- Using an Internet Study to Improve Adherence for Psoriasis PatientsCompletedEarly Phase 1Wake Forest UniversityNCT01802580Written as fluocinonide 0.05% ointment
Codes
What other systems call Fluocinonide · ClinicalTrials.gg INT007505
- MeSH (NLM) D005447FluocinonideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 2W4A77YPANFLUOCINONIDEConfirmed FDA, NLM, Wikidata
- RxNorm 4462Confirmed FDA, Wikidata
- Wikidata Q5462791fluocinonideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C29056FluocinonideOne source FDA
- DrugBank DB01047One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D005447 | Fluocinonide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 2W4A77YPAN | FLUOCINONIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 4462 | — | Confirmed FDA, Wikidata |
| Wikidata | Q5462791 | fluocinonide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C29056 | Fluocinonide | One source FDA |
| DrugBank | DB01047 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.